Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 8.01 (Other Events). DOJ and FTC early termination of HSR waiting period effective November 4, 2026, clearing the antitrust condition.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- DOJ and FTC early termination of HSR waiting period effective November 4, 2026, clearing the antitrust condition
- Merger remains pending, with Company stockholder approval and other closing conditions outstanding
- Transaction converts Lifecore into a wholly owned Parent subsidiary, subject to completion of the merger
- CVR payments remain uncertain, potentially reducing realized shareholder value after closing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.